Apr 3 |
Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
|
Apr 1 |
Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
|
Mar 21 |
Milestone Pharmaceuticals reports Q4 results
|
Feb 29 |
Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference
|
Feb 29 |
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Feb 29 |
Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants
|
Feb 26 |
Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
|
Jan 16 |
Down -43.64% in 4 Weeks, Here's Why Milestone Pharmaceuticals (MIST) Looks Ripe for a Turnaround
|
Jan 2 |
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
|
Dec 27 |
Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
|